Xenon Pharmaceuticals Inc. - Common Stock (XENE)

85 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q4 2020.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,990,190 shares of 77,331,078 outstanding shares and own 36% of the company stock.
Largest 10 shareholders include BVF INC/IL (3,499,346 shares), Avoro Capital Advisors LLC (2,800,000 shares), FMR LLC (2,625,552 shares), ORBIMED ADVISORS LLC (2,497,917 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,450,000 shares), Capital International Investors (1,055,726 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,030,140 shares), NEA Management Company, LLC (992,107 shares), Capital World Investors (963,500 shares), and Bank of New York Mellon Corp (949,238 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.